Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Regularly reviewing your savings progress is essential for success. Discover effective methods to keep track of your financial journey.
20,681 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
As earnings season arrives, investors focus on Axon’s path to durable growth. This article breaks down axon (axon) 20...
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Oklo stock fell 24% over the past month as retail traders on Reddit rally around a bold $250 target by July 4, bracin...
The House advances a sweeping housing bill described as the first major housing since the 1990s, signaling a national...
Saudi Arabia intensifies engagement with Iran as backchannel diplomacy aims to defuse a broader regional crisis. Mark...
Galaxy Digital announced up to $5 million in funding to accelerate Bitcoin's transition to quantum-resistant security...
Cardano is redefining its funding approach for 2026, prioritizing utility and user experience as market conditions ti...
In Washington, governors from both parties pressed for a sweeping review of the nation’s workforce policy amid AI-dri...
U.S. gasoline prices climbed to their highest level since 2023 as the Iran war stretches oil markets. AAA pegged the ...
FTX will begin a fourth distribution to creditors, totaling $2.2 billion, starting March 31. The move comes as the es...
When a company’s top legal officer discloses a stock sale, investors pay attention. This guide explains how to read i...